RES-SAFE (Resorption, Safety, and Efficacy of Absorbable Collagen Membrane)
ConditionGuided Bone Regeneration
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHyundai Bioland Co., Ltd.
About this trial
The clinical study aims to assess the long-term safety and efficacy of the interventional medical device. The clinical study will enrol up to 50 patients aged 18 years and older, who meet specific inclusion and exclusion criteria designed to ensure patient safety and reliable data collection.
Eligibility criteria
Qualifiers
Patients over 18 years old (both sex) with full legal capacity who understand the treatment and sign the informed consent and who are medically healthy, except treated condition.
Disqualifiers
Patients with dental diseases or conditions (except treated condition);
Patients with unsatisfactory oral hygiene;
Patients with alcohol, substance abuse, smoking habits, known allergy to collagen;
Patients with severe or chronic diseases or with systemic inflammation and all patients classified as unhealthy;
Trial design
Treatments tested in this trial
- GBR membrane
Treatment groups
50 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov